← Back to Search

eFRIEND for Aging-Related Frailty

N/A
Waitlist Available
Led By Kathryn E. Callahan, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Must not have
Diagnosis code for dementia in the past 2 years
Does not speak English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6 and month 12
Awards & highlights
No Placebo-Only Group

Summary

This trial involves frail older adults receiving regular check-ins and support from a trained community health worker, either in person or through video calls. The goal is to help these older adults by identifying and addressing any unmet social or functional needs. Community health workers will assess their needs and provide necessary resources and assistance.

Who is the study for?
This trial is for older adults in Forsyth County, NC who are considered frail (eFI>0.21), connected to an ACO registry, have a PCP within the AHWFB system and have visited their clinic in the past year. It's not for those with dementia or non-English speakers.
What is being tested?
The eFRIEND study tests if regular visits and telehealth check-ins with a community health worker can help frail elderly people more than usual care alone by connecting them to helpful resources.
What are the potential side effects?
Since this trial involves social support rather than medical treatment, there aren't typical side effects; however, participants may experience changes in their daily routines or increased interactions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was diagnosed with dementia in the last 2 years.
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6 and month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 and month 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of ED Visits or Inpatient Hospitalizations
Secondary study objectives
Acceptability of Program
Number of Completed Medicare Annual Wellness Visits (AWVs)
Participant Uptake of Home Health Services--Proportion
+15 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Community Health Worker (CHW)-Led Hybrid In-Person/Telehealth Program Pathway (eFRIEND)Experimental Treatment1 Intervention
Participants in the eFRIEND arm will receive regularly scheduled in-person and telehealth contacts with a CHW.
Group II: Usual CareActive Control1 Intervention
Usual care group will be monitored passively for outcomes under a waiver of informed consent
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eFRIEND
2022
N/A
~2050

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,394 Previous Clinical Trials
2,457,986 Total Patients Enrolled
9 Trials studying Aging
3,482 Patients Enrolled for Aging
Kathryn E. Callahan, MDPrincipal InvestigatorAtrium Health Wake Forest Baptist
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

eFRIEND Clinical Trial Eligibility Overview. Trial Name: NCT05293730 — N/A
Aging Research Study Groups: Community Health Worker (CHW)-Led Hybrid In-Person/Telehealth Program Pathway (eFRIEND), Usual Care
Aging Clinical Trial 2023: eFRIEND Highlights & Side Effects. Trial Name: NCT05293730 — N/A
eFRIEND 2023 Treatment Timeline for Medical Study. Trial Name: NCT05293730 — N/A
~647 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top